Skip to content

SLNCF SILENCE THERAPEUTICS PLC

Follow

Ordinary Shares, nominal value 0.05 GBP per share (common), issuer CIK 1479615

No 13F filer reports this security in the loaded quarters.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

Events

  • TCG Crossover GP I, LLC and 2 other reporting persons reported 5,457,105 SLNCF shares, 3.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001193125-26-464018

    Accepted , ingested
  • FMR LLC and 1 other reporting person reported 13,180,206 SLNCF shares, 7.1% of the class, as of 2026-09-30, in a 13G filed 2026-11-05. 0000315066-26-002833

    Accepted , ingested
  • Tetragon Financial Management LP and 3 other reporting persons reported 9,878,565 SLNCF shares, 5.3% of the class, as of 2026-10-05, in a 13G/A filed 2026-10-13. 0000919574-26-006906

    Accepted , ingested
  • Tetragon Financial Management LP and 3 other reporting persons reported 9,708,153 SLNCF shares, 5.2% of the class, as of 2026-10-05, in a 13G filed 2026-10-13. 0000919574-26-006888

    Accepted , ingested